Startseite>>Signaling Pathways>> Microbiology & Virology>> Parasite>>Desethyl chloroquine diphosphate

Desethyl chloroquine diphosphate

Katalog-Nr.GC39372

Desethylchloroquindiphosphat ist ein wichtiger Desethylmetabolit von Chloroquin.

Products are for research use only. Not for human use. We do not sell to patients.

Desethyl chloroquine diphosphate Chemische Struktur

Cas No.: 247912-76-1

Größe Preis Lagerbestand Menge
5mg
360,00 $
Auf Lager
10mg
540,00 $
Auf Lager
25mg
783,00 $
Auf Lager
50mg
1.260,00 $
Auf Lager
100mg
2.025,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Desethyl chloroquine diphosphate is a major desethyl metabolite of Chloroquine. Chloroquine diphosphate is an inhibitor of autophagy and toll-like receptors (TLRs). Desethyl chloroquine diphosphate possesses antiplasmodic activity[1][2].

[1]. Ajayi FO, et al. Comparison of the partitioning in vitro of chloroquine and its desethyl metabolites between the erythrocytes and plasma of healthy subjects and those with falciparum malaria. Afr J Med Med Sci. 1989 Jun;18(2):95-100. [2]. Vodicka P, et al. Assessment of chloroquine treatment for modulating autophagy flux in brain of WT and HD mice. J Huntingtons Dis. 2014;3(2):159-74. [3]. Said A, et al. Chloroquine promotes IL-17 production by CD4+ T cells via p38-dependent IL-23 release by monocyte-derived Langerhans-like cells. J Immunol. 2014 Dec 15;193(12):6135-43.

Bewertungen

Review for Desethyl chloroquine diphosphate

Average Rating: 5 ★★★★★ (Based on Reviews and 6 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Desethyl chloroquine diphosphate

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.